http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200017765-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_645176466e8beb77193a64c3ea9d66c1 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 |
filingDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c402d85b4efc3a8cab1feff12c1bad77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69e8ae170502e048a116c60c7b97f22e |
publicationDate | 2020-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20200017765-A |
titleOfInvention | Micelle comprising polydeoxyribonucleotide, drug delivery matrixs and process for the preparation thereof |
abstract | The present invention relates to a micelle, a drug carrier, and a method for preparing the same, comprising a polydeoxyribonucleotide (PDRN), comprising: a polymer; drug; And a micelle for drug delivery comprising a crosslinking agent, wherein the polymer is poly (ethylene oxide) -b-poly (glycidyl methacrylate) combined with poly (ethylene oxide) and poly (glycidyl methacrylate). Block copolymer, wherein the drug is a polydeoxyribonucleotide (PDRN), and the crosslinking agent is dipropargyl 3,3'-dithiodipropionate containing a disulfide bond. Drug delivery micelles containing PDRN can be prepared simply, and the drug effect can be obtained continuously for a long time by stably protecting the drug and releasing the drug. The micelles produced by the production method of the present invention are PDRN is encapsulated in the fine micelles, ensuring stability during storage, allowing long-term storage and easy handling. In addition, the dispersibility is increased to better disperse in the body to increase the rate of absorption, thereby increasing the efficacy of PDRN. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220101914-A |
priorityDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.